Ï㽶ÊÓƵ

Badly designed studies may lead to the efficacy of drugs being overestimated and money being wasted on trials that prove fruitless, according to a new study from Ï㽶ÊÓƵ in Canada.

Classified as: Research, animal research, mice, Clinical trials, drug trial, sunitinib, preclinical research, animal study, animal models, cancer drug, randomization, blinding, Jonathan Kimmelman, reproducibility, study design, guinea pig
Published on: 14 Oct 2015

Only 11% of drugs that enter clinical trials in humans are ultimately found safe and effective enough to receive regulatory approval.

Classified as: medicine, animal research
Category:
Published on: 24 Jul 2013
Back to top